AbCellera Biologics Inc. (ABCL) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18
	10-K	10-K	10-K	10-K	S-1
Assets
Cash and equivalents	386.5	476.1	594.1	7.6	2.4
Short-term investments					11.3
Accounts receivable, net				3.3	1.6
Inventories					0.0
Other current assets	639.0	453.7	219.2	1.8	1.7
Total current assets	1,025.5	929.8	813.3	12.6	17.0
Property, plant, and equipment, net	217.3	111.6	17.9	8.5	0.2
Intangibles	131.5	148.4	115.2
Goodwill	47.8	47.8	31.5
Long-term investments	72.5	50.3	19.2
Other fixed assets	46.3	30.6	8.4	0.6	0.0
Total assets	1,540.9	1,318.6	1,005.5	23.5	18.1

Accounts payable					0.0
Accrued expenses	50.7	27.0	15.4		0.1
Current portion of long-term debt	0.0	0.0	0.0	2.1	0.0
Current portion of long-term debt				2.1
Deferred revenues				3.2	2.6
Other current liabilities	67.7	93.7	88.1	2.6
Total current liabilities	118.3	120.7	103.5	7.9	2.8
Long-term debt				1.4
Other liabilities	189.3	172.2	71.5	4.0	1.8
Total liabilities	307.6	292.8	175.0	13.2	4.6

Shareholders' equity [+]	1,233.3	1,025.7	830.5	10.3	13.5
Paid-in capital	74.1	35.4	5.9	2.3	0.9
Retained earnings	426.2	267.7	114.2	-4.7	8.8
Tangible shareholders' equity	1,054.0	829.5	683.9	10.3	13.5